Published guidance, NICE advice and quality standards | Guidance

Showing 721 to 730 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Denosumab for the prevention of osteoporotic fractures in postmenopausal women	TA204	27 October 2010	27 October 2010
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)	TA206	27 October 2010	27 October 2010
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)	TA207	27 October 2010	27 October 2010
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C	TA200	22 September 2010	22 September 2010
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis	TA199	25 August 2010	25 August 2010
Capecitabine for the treatment of advanced gastric cancer	TA191	28 July 2010	28 July 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer	TA192	28 July 2010	28 July 2010
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia	TA193	28 July 2010	28 July 2010
Human growth hormone (somatropin) for the treatment of growth failure in children	TA188	26 May 2010	26 May 2010